Figure 1. Relation between interleukin (IL)-6 and high-sensitivity C-reactive protein (hsCRP) or vascular endothelial growth factors (VEGF) in the inflammatory stage of Eale’s disease (ED). A: The correlation between the serum levels of interleukin-6 (IL-6) and high-sensitivity C-reactive protein (hsCRP) from 41 patients with Eales’ disease (ED) at the inflammatory stage. The IL-6 levels in serum correlated significantly with serum hsCRP levels (Spearman’s correlation coefficient; r=0.4992, p=0.0009). The solid line represents the linear regression curve of the best fit. B: The correlation between the serum levels of IL-6 and vascular endothelial growth factor (VEGF) from 41 patients with ED at the inflammatory stage. No significant relation was seen between serum IL-6 levels and serum VEGF levels in the inflammatory stage (Spearman’s correlation coefficient; r=0.08811, p=0.5838). The solid line represents the linear regression curve of the best fit.